(Updated 3:17 p.m.)
CVS Pharmacy Inc. will pay $3.5 million to settle allegations that 50 of its Massachusetts stores violated the Controlled Substances Act by filling forged prescriptions for addictive painkillers and other controlled substances more than 500 times between 2011 and 2014.
Summer is here, and for many in New England, that means trips to destinations domestic and abroad. An all-time record 231 million passengers are expected to fly U.S. airlines between June 1 and August 31, up from 210 million a year ago, according to Airlines for America. That includes 30.5 million travelers on international flights.
Sometimes, the heart just wants what it wants.
Medtronic, a maker of heart-rhythm devices, announced on Monday that it's paying $1.1 billion for HeartWare International, whose own devices reduce surgical invasiveness when treating patients with heart failure.
Medtronic PLC, the world’s biggest maker of heart-rhythm devices, agreed to buy HeartWare International Inc. for about $1.1 billion, paying a premium of 93 percent to gain less-invasive technology for treating advanced heart-failure patients.
The Tufts Health Plan Foundation announced June 23 an investment of $80,000 to Saint Elizabeth Community in Providence to pilot WellCare, an initiative that coordinates care to help older adults living in subsidized housing manage their chronic diseases and live independently. By integrating health services across community-based organizations, the program aims to improve access to care for vulnerable populations.